733
edits
Brugada Syndrome: Difference between revisions
Jump to navigation
Jump to search
→Medication/Other therapies:
mNo edit summary |
|||
| Line 77: | Line 77: | ||
==='''Medication/Other therapies:'''=== | ==='''Medication/Other therapies:'''=== | ||
*[[ICD]] implantation is first line therapy in Brugada patients with a previous cardiac arrest, [ | *[[ICD]] implantation is first line therapy in Brugada patients with a previous cardiac arrest, [[ventricular tachycardia]] or cardiac [[syncope]]. ICD implantation in asymptomatic patients is not advised and needs careful judgement regarding the low annual rate of arrhythmic events and high incidence rate of complications (7.5 per 100 patient-years). | ||
*In Brugada patients with recurrent VF events or ICD shocks, isoproterenol or quinidine are known to be effective for VF suppression in both children and adults. | *In Brugada patients with recurrent VF events or ICD shocks, isoproterenol or quinidine are known to be effective for VF suppression in both children and adults. | ||
*Ablation of a fractionated electrogram in the epicardial right ventricular outflow tract is a promising option for VF suppression in Brugada patients in a small study, but still has to be proven in larger cohorts of Brugada patients. | *Ablation of a fractionated electrogram in the epicardial right ventricular outflow tract is a promising option for VF suppression in Brugada patients in a small study, but still has to be proven in larger cohorts of Brugada patients. | ||